The life science industry is fully aware of the guidance around site monitoring and it is widely known
and accepted to be one of the most costly and resource-intensive functions of any clinical trial.
Currently it is estimated almost one third of the cost of a clinical trial is spent on monitoring activities.
To date, most sponsors and contract research organizations (CROs) have primarily invested in
electronic data capture (EDC) as a technology that offers the promise of reducing the time to
submission from database lock therefore enabling them to expedite the submission process and gain